Pharmacologic reversal of serious or intolerable side effects (SISEs) from vasodilator stress
is an important safety and comfort measure for patients experiencing such effects. While …

Background Coronary microvascular dysfunction (CMD) is the leading cause of ischemia
with no obstructive coronary arteries disease (INOCA) disease. Diagnosis of CMD relies on …

Background Although heart rate response (HRR) to regadenoson stress has been shown to
be a strong predictor of outcome, it has not been investigated in a large all-comers cohort …

Background Although there are studies examining each one separately, there are no data in
the literature comparing the magnitudes of the iatrogenic, percutaneous coronary …

Myocardial perfusion imaging (MPI) with single photon emission computed tomography
(SPECT) or positron emission tomography (PET) is a widely used technique for the …

Background There are limited data on the prognostic utility of regadenoson SPECT
myocardial perfusion imaging (MPI) in patients with end-stage renal disease (ESRD) …

Background Data on the prognostic value of regadenoson SPECT myocardial perfusion
imaging (MPI) is limited and based on small cohorts. Methods and Results We conducted a …

Background Data on the diagnostic and prognostic value of subtle abnormalities on
myocardial perfusion imaging (MPI) are limited. Methods and results In a retrospective …

A large body of evidence has been generated in support of the use of myocardial perfusion
imaging (MPI), in the diagnostic and prognostic assessment of patients with suspected …

Abstract Purpose of Review To examine the utility and methods of coronary artery disease
(CAD) assessment in patients with new-onset heart failure with reduced ejection fraction …